Vanguard Tax-Managed International Fund ETF Shares (VEA)
| 39.01 Data as of May 17 |  +0.32 / +0.83%Today’s Change | 28.75 Today|||52-Week Range 39.10 | +10.73% Year-to-Date |
Investment Objective
The investment seeks to provide a tax-efficient investment return consisting of long-term capital appreciation. The fund purchases stocks included in the MSCI EAFE Index, which is made up of approximately 925 common stocks of companies located in 22 countries in Europe, Australia, Asia, and the Far East. It uses statistical methods to "sample" the index, aiming to closely track its investment performance while limiting investments in index securities that have undesirable tax characteristics in an attempt to minimize taxable income distributions.
Latest VEA News
No recent news for Vanguard Tax-Managed International Fund ETF Shares.
Performance
| 1 month | +7.10% | 3 years | +11.35% | |
| 3 months | +7.93% | 5 years | -1.11% | |
| 1 year | +34.21% | Since inception | -1.29% |
Data through 05/18/2013
Quote Details
| Previous close | $38.69 |
| Open day’s range | -- – -- |
| Net asset value (NAV) | 38.90 (05/17/2013) |
| Daily volume | 1,845,777 |
| Average volume (3 months) | 2,920,397 |
Data as of 4:00pm ET, 05/17/2013
Peer Comparisonvs. Foreign large blend ETFs
| VEA | Category | |
|---|---|---|
| Performance 5-yr return | -1.11% | -0.28% |
| Expense Gross exp ratio | 0.10% | 0.42% |
| Risk 5 year sharpe ratio | 0.08 | 0.09 |
| Net assets | $15.7B | $3.3B |
| Average market cap | $32.8B | $35.1B |
| Average P/E | 13.2 | 13.9 |
| Dividend / Share | -- | 0.42% |
Competitors
Holdings
Top 5 SectorsPortfolio weighting
| Financial service | 22.06% |
| Industrial materials | 21.75% |
| Consumer goods | 16.79% |
| Healthcare | 8.42% |
| Energy | 8.02% |
Top 10 HoldingsPortfolio weighting
| -- Nestle SA | 2.03% |
| -- HSBC Holdings PLC | 1.69% |
| -- Novartis AG | 1.43% |
| -- Roche Holding AG | 1.43% |
| -- Toyota Motor Corp | 1.24% |
| -- Vodafone Group PLC | 1.21% |
| -- BP PLC | 1.17% |
| -- Sanofi | 1.06% |
| -- Royal Dutch Shell PLC Class A | 1.05% |
| -- GlaxoSmithKline PLC | 1.01% |